CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Clearmind Medicine Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026
$6.00−0.26 (-4.15%)
Close on Oct 19, 2026
- Market cap
- $9.49M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Clearmind Medicine from other investors
No posts about CMND yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.